Cover Image
Market Research Report
Product code 

Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Published: | Mordor Intelligence Pvt Ltd | 120 Pages | Delivery time: 2-3 business days


Back to Top
Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
Published: January 17, 2022
Mordor Intelligence Pvt Ltd
Content info: 120 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

The enteral feeding devices market was valued at approximately USD 2,850 million in 2020 and is expected to witness a revenue of USD 3,985 million in 2026, with a CAGR of 6.2% over the forecast period (2021-2026).

The current pandemic of COVID-19 is expected to significantly impact the enteral feeding devices market globally. According to the research article published in Critical Care, 2020, the SARS-CoV2 virus infects the respiratory tract and is also predicted to invade the gastrointestinal tract, neurological systems, and kidneys, which may affect the nutrition delivery among COVID-19 patients. According to the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, Gastric Enteral Nutrition is advised for severe COVID-19 patients and should be preferably performed using a pump with a flow regulator, within 48 hours of admission to the ICU. Hence, the COVID-19 pandemic has increased the need for enteral feeding devices, especially for those in intensive care units, and thus, has been driving the studied market.

The factors that are responsible for the growth of the market include an increasing population of geriatrics, higher premature births, growing adoption of enteral nutrition, and higher prevalence of chronic diseases.

The global population is aging at a fast pace due to reduced birth rates and increasing life expectancy. According to the United Nations' World Population Ageing 2019 report, there were an estimated 703 million people aged 65 years, globally, in 2019, and this number is expected to reach to 1.5 billion by 2050. As an alternative to conventional nutritional intake, enteral feeding is administered to elderly patients who have difficulty in swallowing, digestion, and assimilation, and thus, this increase of the geriatric population acts as a major factor for the growth of the studied market.

Additionally, according to World Health Organization, 2018, an estimated 15 million babies are born preterm every year and this number is expected to rise over the years. The premature babies have higher nutritional requirements in the neonatal period and early initiation of enteral nutrition could benefit premature babies. Hence, in view of the aforementioned factors, the enteral feeding devices market is expected to witness a significant growth over the forecast period.

Key Market Trends

Application in Diabetes is Expected to Register a Good Growth during the Forecast Period

For patients with diabetes, the enteral feeding regimen is recommended by the dietitian to meet the individual's nutritional requirements. Special high-protein diabetes-specific formulas are administered through the enteral feeding tubes, which reduce the insulin need for the patients. This leads to improved glycemic control, which is important for the longevity of the patient. Additionally, enteral nutrition lacks cholesterol and thereby aids in cholesterol control in diabetic patients. The development of insulin resistance can also be minimized using continuous saccharide delivery with appropriate caloric content. According to the research article published in Nutrients, in 2019, the Diabetes- Specific Formula has improved glycemic control through delay in gastric emptying, delayed intestinal absorption of carbohydrate and lower glycemic response, and was found to be effective in increasing High-Density Lipid (HDL) cholesterol levels. Furthermore, as per the research article published in the Lancet, Diabetes, and Endocrinology, 2020, the COVID-19 virus can severely affect diabetic patients as it can precipitate acute metabolic complications through direct negative effects on B-cell function. This impairment on the B-cell function can cause diabetic ketoacidosis in diabetic patients, hyperglycemia at hospital admission in individuals with unknown history of diabetes, and potentially new-onset diabetes, which is expected to surge the demand for enteral feeding devices for the management of diabetes. Hence, COVID-19 is expected to highly impact the studied segment during the pandemic.

Moreover, incidences of diabetes have increased over the years globally, and is expected to increase further. As per a 2019 report by the Internation Diabetes Federation, the global incidence of diabetes is expected to increase from 463 million in 2019 to 578 million by 2030. Thus, these factors play a major role in increasing the demand for enteral feeding devices, which will likely boost the market growth.

North America is Expected to Dominate the Enteral Feeding Devices Market Over the Forecast Period

The North American region, particularly the United States has a developed and well-structured health care system. The region is a hub for research and development activities and encourages key players to establish their headquarters in the region through its policies and investment support . As a result, these countries enjoy the presence of many global market players.

Also, the growing burden of chronic diseases and geriatric population in the region is expected to drive the demand for enteral feeding devices, to support the nutritional requirements of individuals who can not ingest and digest food. According to the Population Reference Bureau's Population Bulletin" Aging in the United States the Americans aged 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060. The current pandemic of COVID-19 is expected to propel the use of enteral feeding devices market in the United States. The highest number of COVID-19 infected patients as per John Hopkins COVID-19 Tracker are reported in the United States and as Enteral nutrition is recommended by the Society of Critical Care Medicine and the American Society for Parenteral and Enteral Nutrition, over the first few weeks of critical illness by COVID-19 infection, to meet the energy goal of 15-20kcal/Kg actual body weight/dayand protein goal of 1.2-2.0 gm/kg ABW/day. Hence, Enteral feeding devices market is expected to propel over the current COVID-19 pandemic era.

Additionally, the increasing product approvals is expected to drive the market growth. For instance, in Oct 2019, Fidmi Medical received 510(k) clearancefrom FDA for its low-profile enteral feeding device, a gastronomy tube designed to deliver nutrients to patients. Thus, in view of the aforementioned factors, th estudied market is expected to propel significantly in North America overthe forecast period.

Competitive Landscape

The enteral feeding devices market is highly competitive. In terms of market share, several companies, such as B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cardinal Health, and Becton Dickinson and Company, among others, hold the largest market shares. The key players are evolving through various strategic alliances, such as acquisitions, collaborations, and new product launches, to expand the global product portfolio and secure their positions in the global market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Product Code: 56088



  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases
    • 4.2.2 Increasing Number of Premature Births
    • 4.2.3 Growing Demand for Enteral Feeding in Home Care Settings
  • 4.3 Market Restraints
    • 4.3.1 Complications Associated with Enteral Feeding Tubes
    • 4.3.2 Healthcare Reimbursement Issues
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product Type
    • 5.1.1 Enteral Feeding Pumps
    • 5.1.2 Enteral Feeding Tubes
    • 5.1.3 Other Product Types
  • 5.2 By Age Group
    • 5.2.1 Adults
    • 5.2.2 Pediatrics
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Care Services
    • 5.3.3 Other End Users
  • 5.4 By Application
    • 5.4.1 Oncology
    • 5.4.2 Neurology
    • 5.4.3 Critical Care
    • 5.4.4 Diabetes
    • 5.4.5 Gastroenterology
    • 5.4.6 Other Applications
  • 5.5 Geography
    • 5.5.1 North America
      • United States
      • Canada
      • Mexico
    • 5.5.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.5.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • 5.5.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 B. Braun Melsungen AG
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Conmed Corporation
    • 6.1.5 Cook Medical Inc.
    • 6.1.6 Fresenius SE & Co. KGaA
    • 6.1.7 Halyard Health Inc.
    • 6.1.8 Danone Medical Nutrition (Nutricia)
    • 6.1.9 Moog Inc.
    • 6.1.10 Nestle SA
    • 6.1.11 Avanos Medical, Inc.
    • 6.1.12 Cardinal Health, Inc.
    • 6.1.13 Becton Dickinson and Company
    • 6.1.14 Vygon SA
    • 6.1.15 Applied Medical technology, Inc.
    • 6.1.16 Amsino International Inc.
    • 6.1.17 Fidmi Medical
    • 6.1.18 ALCOR Scientific, Inc.
    • 6.1.19 MEDELA Inc
    • 6.1.20 Vesco Medical LLC